What we are, what we are not, and how the supply chain works.
Peptide programs sit inside a real regulatory framework. This page sets out our role, our partners' roles, and the limits on all of it — plainly, so a clinic can assess us before a call rather than after.
Revival RX Partners is a consulting and sourcing partner.
We are not a pharmacy. We do not compound, dispense, label, or ship medication. We do not hold a pharmacy licence and we do not take possession of the products your patients receive.
We are not a medical practice. We do not prescribe, diagnose, or treat, and nothing we provide is medical advice. Clinical decisions belong to a licensed practitioner exercising independent judgment for a specific patient.
What we do is operational: we help a clinic design a peptide service line, open accounts with licensed partner pharmacies, build the workflows and staff training around it, and support the rollout for ninety days.
503(a) and 503(b), and why the distinction matters.
Compounded medications reach patients through two different kinds of facility, and which one applies changes what a clinic can legally do with the product.
- 503(a) — patient-specific compounding
- A traditional compounding pharmacy preparing a medication for one identified patient against a valid prescription. Product cannot be compounded in advance for office stock. This is the path most peptide protocols follow.
- 503(b) — outsourcing facility
- An FDA-registered facility that may compound in larger batches and, in defined circumstances, supply product for office use. Subject to CGMP requirements and FDA inspection. Availability varies by compound.
Orders route to whichever facility type is appropriate for the compound, the state, and the prescription. Partner pharmacies dispense against valid prescriptions issued by your clinic's prescribers, or by prescribers in the partner network, and ship directly.
Compounded peptides are not FDA-approved products.
Compounded preparations are not reviewed by the FDA for safety, efficacy, or manufacturing quality before they reach a patient. That is a structural feature of compounding, not a criticism of any particular pharmacy.
Which peptides may be compounded is actively changing. Substances move between FDA bulk-substance categories, and facilities adjust what they will prepare in response. Availability of any specific compound may change without notice, and nothing on this site should be read as a guarantee that a given product will remain available.
We describe compounds by category and mechanism. We do not make claims about clinical outcomes for any compounded preparation.
Independent practitioners, licensed where they prescribe.
Launch Program clinics can access prescriber coverage across all fifty states through our nurse-practitioner platform partner. Those prescribers are independent licensed practitioners. They are not employed by Revival RX Partners, and we do not direct their clinical decisions.
A prescriber may only treat a patient in a state where that prescriber holds an active licence. Telehealth, good-faith-examination, and scope-of-practice rules vary by state, and the partner platform is responsible for matching each patient to an appropriately licensed practitioner.
No compensation we pay or receive is tied to the volume or value of any individual prescription.
HIPAA, and where the responsibility actually sits.
Your clinic is the covered entity. Partner pharmacies and the prescriber platform handle protected health information under their own obligations. Revival RX Partners does not require access to your patients' protected health information to deliver the Launch Program, and does not process it as a matter of course.
Where a specific engagement would involve protected health information, that is handled under a written business associate agreement executed before any data changes hands. Saying a system is 'HIPAA compliant' is not a certification anyone issues — compliance is a property of how an organisation operates, and each party is responsible for its own.
What a clinic can and cannot say.
Advertising rules for compounded medications are restrictive and enforced. Compounded preparations may not be advertised as safe, effective, or approved, and claims about specific clinical outcomes create real exposure for the clinic making them.
Major advertising platforms independently restrict or prohibit this category, and those policies change frequently. The marketing work inside the Launch Program is built around your existing patient base and channels that fit the category. We do not promise placement on any specific platform.
In short
- Revival RX Partners is not a pharmacy, is not a prescriber, and does not practise medicine.
- All medication is dispensed by licensed partner pharmacies against valid prescriptions.
- Compounded peptides are not FDA-approved. Availability and regulatory status change.
- Nothing on this site is medical advice, and nothing here guarantees revenue or clinical outcomes.
- Clinics remain responsible for their own licensure, scope of practice, and advertising.
Compliance questions before a call are welcome — raise them on the application and we will answer them directly rather than deferring to a form.
Compliance questions.
Does Revival RX Partners hold a pharmacy licence?
Who is responsible if a state regulator asks about our peptide program?
Can we advertise specific peptides to patients?
Do you have a business associate agreement?
What happens if a compound we are selling becomes unavailable?
Your patients are already asking about peptides.Make sure your clinic is ready to answer.
Build and launch your peptide program with Revival RX Partners in 90 days.
Important
- Revival RX Partners is a consulting and sourcing partner. It is not a pharmacy, does not compound or dispense medication, and does not practice medicine or provide medical advice.
- All medications are dispensed by licensed partner pharmacies against valid prescriptions issued by your clinic's licensed prescribers.
- Compounded peptides are not FDA-approved products. Availability, regulatory status, and pharmacy capability vary by compound and by state, and are subject to change.
- Nothing on this page is a guarantee of revenue, patient volume, or clinical outcomes. Revenue figures shown are illustrative and generated from values you enter.